Ulyana Dashkevych
Hematology & Oncology · Tucson, AZNPI 1346861721
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,018 of the $5,409 with a category attached, or 74.3%. It is spread thinly across 38 manufacturers, the largest accounting for just 16.2%. 2025 is the largest year on record at $3,051, more than ten times the $50 reported in 2022. That places this record below the midpoint for hematology & oncology clinicians in AZ, where the typical reported total is $6,870.
Across 112 payments — averaging $48.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$874
- Johnson & Johnson$678
- Ipsen Biopharmaceuticals, Inc$355
- Sanofi-aventis U.S. LLC$320
- AstraZeneca$286
- AbbVie$282
- plus $3K from 32 others
What the payments were for
- Speaking & faculty fees$2094%
- Food & beverage$4,01874%
- Education$1,18322%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 13 | $874 |
| Johnson & Johnson | 14 | $678 |
| Ipsen Biopharmaceuticals, Inc | 3 | $355 |
| Sanofi-aventis U.S. LLC | 3 | $320 |
| AstraZeneca | 6 | $286 |
| AbbVie | 4 | $282 |
| Rigel Pharmaceuticals, Inc. | 3 | $274 |
| Sanofi | 5 | $231 |
| Pfizer | 11 | $206 |
| Seagen Inc. | 2 | $193 |
| Geron Corporation | 3 | $171 |
| Daiichi Sankyo Inc. | 6 | $148 |
| GSK | 4 | $134 |
| Stemline Therapeutics Inc. | 1 | $125 |
| Sumitomo Pharma America, Inc. | 2 | $125 |
| Sobi, Inc | 3 | $122 |
| Karyopharm Therapeutics Inc. | 1 | $122 |
| E.r. Squibb & Sons, L.L.C. | 1 | $86 |
| Tempus AI, Inc | 1 | $79 |
| Genentech USA, Inc. | 3 | $67 |
| Pharmacosmos Therapeutics Inc. | 1 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $51 |
| Deciphera Pharmaceuticals Inc. | 2 | $46 |
| Merck | 2 | $41 |
| Gilead | 2 | $40 |
| Novartis | 2 | $39 |
| Regeneron Healthcare Solutions, Inc. | 1 | $37 |
| Blueprint Medicines Corporation | 1 | $32 |
| Beigene USA, Inc. | 1 | $29 |
| Fresenius Kabi USA, LLC | 1 | $25 |
| Bayer | 1 | $20 |
| Eisai Inc. | 1 | $17 |
| Boehringer Ingelheim | 1 | $17 |
| Morphosys, US Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
| AVEO Pharmaceuticals, Inc. | 1 | $16 |
| Apellis Pharmaceuticals, Inc. | 1 | $15 |
| Janssen Scientific Affairs, LLC | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,409 in reported general payments places this provider in the 45th percentile of 261 hematology & oncology providers in Arizona.
Other hematology & oncology in Tucson
- Christopher ChenTucson$370K
- Rachna ShroffTucson$250K
- Alison StopeckTucson$115K
- Jaspreet ChahalTucson$104K
- Basel ShouaTucson$98K
- Akshay AmaraneniTucson$93K
- Ahmed AbdelazizTucson$35K
- Michael BoxerTucson$30K
- Catherine AzarTucson$29K
- Ricklie JulianTucson$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.